1. European Commission: Legal provisions of SWD (2013)436 - Use of “-omics” technologies in the development of personalised medicine (2013). https://www.eumonitor.eu/9353000/1/j4nvhdfcs8bljza_j9vvik7m1c3gyxp/vje6rupawyzf
2. Slim, K., Selvy, M., Veziant J.: Conceptual innovation: 4P Medicine and 4P surgery. J. Vis. Surg. 158 (2021). https://doi.org/10.1016/j.jviscsurg.2021.01.003
3. Kisor, D., Ehret, M.: The personalized medicine report (2020). https://www.personalizedmedicinecoalition.org/Userfiles/PMC-Corporate/file/PMC_The_Personalized_Medicine_Report_Opportunity_Challenges_and_the_Future.pdf
4. Leyens, L., Hackenitz, E.: CSA Permed: Europe’s commitment to personalised medicine. Eurohealth Int. 20 (2014). https://www.permed2020.eu
5. Personalised medicine in the Nordic countries NOS-M report with conclusions and recommendations for joint actions in personalised medicine in the Nordic countries. https://nos-m.org/news/nordic-common-strengths-and-future-potential-in-the-field-of-personalised-medicine